Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
Kyobu Geka. the Japanese Journal of Thoracic Surgery|July 27, 2023
[Clinicopathological Features and Imaging Characteristics of Pulmonary Mucosa-associated Lymphoid Tissue Lymphoma]Naoyuki Oka, Kyohei Masai, Yu Okubo, et al.The Annals of Thoracic Surgery|May 29, 2017
A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor SizeShigeki Suzuki, Hiroyuki Sakurai, Kyohei Masai, et al.Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Cytokeratin 19 expression in primary thoracic tumors and lymph node metastasesKyohei Masai, Kazuo Nakagawa, Akihiko Yoshida, et al.Cureus|September 19, 2025
Clinical Characteristics and Indicators of Spontaneous Hemopneumothorax Comparing With Primary Spontaneous PneumothoraxMikito Suzuki, Kaoru Kaseda, Kaito Yano, et al.Kyobu Geka. the Japanese Journal of Thoracic Surgery|May 15, 2018
[Role of Surgery in Multimodality Treatment for Non-small Cell Lung Cancer;Current Status and Future Perspectives]Toshiyuki Shima, Kyohei Masai, Tomoyuki Hishida, et al.Journal of Cardiothoracic Surgery|April 10, 2026
Lobectomy results in a greater increase in the pulmonary artery to aorta ratio compared to sublobar resection: a retrospective studyTaketo Nakai, Yu Okubo, Takahiro Suzuki, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|May 9, 2014
p40 is the best marker for diagnosing pulmonary squamous cell carcinoma: comparison with p63, cytokeratin 5/6, desmocollin-3, and sox2Takahiro Tatsumori, Koji Tsuta, Kyohei Masai, et al.Chest|April 9, 2022
A 70-Year-Old Woman With Long-Term Nonresolving PneumoniaSaki Tomiyasu, Hiroki Kabata, Katsura Emoto, et al.The Annals of Thoracic Surgery|February 11, 2018
Clinical Features of Ground Glass Opacity-Dominant Lung Cancer Exceeding 3.0 cm in the Whole Tumor SizeShigeki Suzuki, Hiroyuki Sakurai, Masaya Yotsukura, et al.General Thoracic and Cardiovascular Surgery|September 26, 2024
Survival impact of pathologic features after salvage lung resection following definitive chemoradiotherapy or systemic therapy for initially unresectable lung cancerNaoyuki Oka, Tomoyuki Hishida, Kaoru Kaseda, et al.Pageof 5